L&C Bio Co. Ltd (290650) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.014x

Based on the latest financial reports, L&C Bio Co. Ltd (290650) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.79 Billion ≈ $2.57 Million USD) by net assets (₩266.71 Billion ≈ $180.74 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

L&C Bio Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how L&C Bio Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of L&C Bio Co. Ltd for a breakdown of total debt and financial obligations.

L&C Bio Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of L&C Bio Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Zhejiang Jingxing Paper Joint Stock Co Ltd SHE:002067	0.020x
Neuberger Berman Next Generation Connectivity Fund Inc NYSE:NBXG	N/A
Nazara Technologies Limited NSE:NAZARA	0.009x
Trupanion Inc NASDAQ:TRUP	0.076x
Alvotech IC:ALVO	0.314x
Whirlpool China Co Ltd SHG:600983	0.063x
Nanjing Red Sun Co Ltd SHE:000525	0.021x
Shandong Nanshan Zhishang Sci-Tech Co.Ltd. SHE:300918	-0.024x

Annual Cash Flow Conversion Efficiency for L&C Bio Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of L&C Bio Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see 290650 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩284.35 Billion ≈ $192.70 Million	₩-8.57 Billion ≈ $-5.81 Million	-0.030x	+63.51%
2023-12-31	₩146.94 Billion ≈ $99.58 Million	₩-12.13 Billion ≈ $-8.22 Million	-0.083x	-33.11%
2022-12-31	₩97.95 Billion ≈ $66.38 Million	₩-6.08 Billion ≈ $-4.12 Million	-0.062x	-148.35%
2021-12-31	₩85.02 Billion ≈ $57.62 Million	₩10.91 Billion ≈ $7.39 Million	0.128x	-0.05%
2020-12-31	₩57.81 Billion ≈ $39.17 Million	₩7.42 Billion ≈ $5.03 Million	0.128x	+16.12%
2019-12-31	₩58.18 Billion ≈ $39.43 Million	₩6.43 Billion ≈ $4.36 Million	0.111x	+50.78%
2018-12-31	₩52.46 Billion ≈ $35.55 Million	₩3.85 Billion ≈ $2.61 Million	0.073x	-67.72%
2017-12-31	₩16.81 Billion ≈ $11.39 Million	₩3.82 Billion ≈ $2.59 Million	0.227x	+1327.62%
2016-12-31	₩10.02 Billion ≈ $6.79 Million	₩-185.35 Million ≈ $-125.61K	-0.018x	+94.55%
2015-12-31	₩3.91 Billion ≈ $2.65 Million	₩-1.33 Billion ≈ $-899.78K	-0.339x	--

About L&C Bio Co. Ltd

KQ:290650 Korea Medical Devices

Market Cap

$1.05 Billion

₩1.56 Trillion KRW

Market Cap Rank

#8872 Global

#250 in Korea

Share Price

₩63200.00

Change (1 day)

-9.59%

52-Week Range

₩22400.00 - ₩118300.00

All Time High

₩118300.00